The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Olisova O.Iu.

I.M. Sechenov First State Moscow Medical University

Dodina M.I.

Pervyĭ MGMU im. I.M.Sechenova

Kushlinskiĭ N.E.

Rossiĭskiĭ onkologicheskiĭ nauchnyĭ tsentr im. N.N. Blokhina RAMN, Moskva

The role of vascular endothelial growth factor in pathogenesis of rosacea and its medicamental correction

Authors:

Olisova O.Iu., Dodina M.I., Kushlinskiĭ N.E.

More about the authors

Journal: Russian Journal of Clinical Dermatology and Venereology. 2012;10(1): 49‑55

Read: 12380 times

Download PDF (RU)
Contact the author
Table of contents

THE ROLE OF VASCULAR ENDOTHELIAL GROWTH FACTOR IN PATHOGENESIS OF ROSACEA AND ITS MEDICAMENTAL CORRECTION
THE ROLE OF VASCULAR ENDOTHELIAL GROWTH FACTOR IN PATHOGENESIS OF ROSACEA AND ITS MEDICAMENTAL CORRECTION

To cite this article:

Olisova OIu, Dodina MI, Kushlinskiĭ NE. The role of vascular endothelial growth factor in pathogenesis of rosacea and its medicamental correction. Russian Journal of Clinical Dermatology and Venereology. 2012;10(1):49‑55. (In Russ.)

Подписка 2026 Клиническая дерматология и венерология (Russian Journal of Clinical Dermatology and Venereology)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Clinical and anamnestic features of rosa­cea in women in peri­menopausal period. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(1):49-55
Damage of human skin barrier components in expo­sure of Demo­dex specimens. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(2):219-226
Expe­rience of comprehensive treatment of erythematotelangiectatic rosa­cea. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(2):236-239
Angiopausin concentrate for skin prone to redness. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(3):369-374
Features of pero­xide-antioxidant imba­lance in patients with rosa­cea and approaches to comprehensive therapy. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(4):439-444
Hardware technologies in rosa­cea treatment. Russian Journal of Clinical Dermatology and Vene­reology. 2025;(6):814-821
Asse­ssment of the change over time of serum matrix meta­lloproteinases and vascular endo­thelial growth factor in the acute period of ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(12-2):13-20
Abstract:

Keywords:

rosacea
vascular endothelial growth factor
Pimecrolimus cream
1%

Authors:

Olisova O.Iu.

I.M. Sechenov First State Moscow Medical University

Dodina M.I.

Pervyĭ MGMU im. I.M.Sechenova

Kushlinskiĭ N.E.

Rossiĭskiĭ onkologicheskiĭ nauchnyĭ tsentr im. N.N. Blokhina RAMN, Moskva

Close metadata

References:

  1. Potekaev N.N. Akne i rozatsea. M: Binom 2007.
  2. Samtsov A.V. Akne i akneformnye dermatozy. M 2009.
  3. Rohrich R.J., Griffin J.R., Adams W.P. Rhinophyma: review and update. Plast Reconstr Surg 2002; 110: 3: 860-869.
  4. Scheinfeld N.S. Rosacea. Skinmed 2006; 5: 4: 191-194.
  5. Monakhov K.N., Yakubovskii A.V. Evolyutsiya predstavlenii o proiskhozhdenii i lechenii rozatsea. Plasticheskaya khirurgiya i kosmetologiya 2009; Prezentatsionnyi nomer:79-88.
  6. Potekaev N.N. Rozatsea (etiologiya, klinika, terapiya). M: Binom - SPb: Nevskii Dialekt 2000.
  7. Bystritskaya E.A., Bystritskaya T.F., Chernakova N.N. Kompleksnyi podkhod k lecheniyu rozatsea, demodikoza i akne u patsientok srednei vozrastnoi gruppy. Klin dermatol i venerol 2006; 4: 29-31.
  8. Olisova O.Yu. Patogeneticheskie podkhody v lechenii steroidnoi rozatsea. Eksp i klin dermatokosmetol 2008; 5: 44-47.
  9. Kusaya N.V. Osobennosti immunnogo i tsitokinovogo statusa u patsientov s demodikozom kozhi: Avtoref. dis. … kand. med. nauk. Vladivostok 2009.
  10. Yamasaki K., Di Nardo A., Bardan A. et al. Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea. Nat Med 2007; 13: 8: 975-980.
  11. Culp B., Scheinfeld N. Rosacea: A review. Pharm Ther 2009; 34: 1: 38-45.
  12. Crawford G.H., Pelle M.T., James W.D. Rosacea: I. Etiology, pathogenesis, and subtype classification. J Am Acad Dermatol 2004; 51: 3: 327-344.
  13. Diamantis S., Waldotf H.A. Rosacea: clinical presentation and pathophysiology. J Drugs Dermatol 2006; 5: 1: 8-12.
  14. Il'ina I.V., Sanakoeva E.G., Masyukova S.A. Sovremennyi vzglyad na patogenez rozatsea. Eksp i klin dermatokosmetol 2011; 1: 18-20.
  15. Del Rosso J.Q. A status report on the medical management of rosacea: focus on topical therapies. Cutis 2002; 70: 5: 271-275.
  16. Weissenbacher S., Merkl J., Hildebandt B. et al. Pimecrolimus cream 1% for papulopustular rosacea: a randomized vehicle-controlled double-blind trial. Br J Dermatol 2007; 156: 4: 728-732.
  17. Kochergin N.G., Rumyantseva E.E., Kondrashov G.V., Traksel' L.V. Pimekrolimus pri immunodermatozakh. Rus med zhurn 2003; 11: 17: 953-956.
  18. Hultsch T., Müller K.D., Meingassner J.G. et al. Ascomycin macrolactam derivative SDZ ASM 981inhibits the release of granule-associated mediators and of newly synthesized cytokines in RBL 2H3 mast cells in an immunophilin-dependent manner. Arch Dermatol Res 1998; 290: 9: 501-507.
  19. Goldman D. Tacrolimus ointment for the treatment of steroid-induced rosacea: a preliminary report. J Am Acad Dermatol 2001; 44: 6: 995-998.
  20. Chu C.Y. The use of 1% pimecrolimus cream for the treatment of steroid-induced rosacea. Br J Dermatol 2005; 152: 2: 396-399.
  21. Frank S., Hübner G., Breier G. et al. Regulation of vascular endothelial growth factor expression in cultured keratinocytes. Implications for normal and impaired wound healing. J Biol Chem 1995; 270: 21: 12607-12613.
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.